» Authors » Paolo Di Bartolo

Paolo Di Bartolo

Explore the profile of Paolo Di Bartolo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 51
Citations 620
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
De Cosmo S, Pontremoli R, Giandalia A, Manicardi V, Rocca A, Nicolucci A, et al.
J Nephrol . 2024 Dec; PMID: 39676127
Background: We evaluated the proportion of Type 2 diabetes (T2D) patients with chronic kidney disease (CKD) participating in the AMD (Association of Medical Diabetologists) Annals initiative who met the eligibility...
2.
Gamarra E, Trimboli P, Careddu G, Fazi A, Turra V, Morelli A, et al.
Diabetes Res Clin Pract . 2024 Dec; 219():111945. PMID: 39644976
Background And Aims: Scuba diving for people with diabetes was discouraged due to hypoglycemia risks. However, evolving guidelines now enable safe diving for people with diabetes. Among them, the Diabete...
3.
Russo G, Nicolucci A, Lucisano G, Rossi M, Ceriello A, Prattichizzo F, et al.
Diabetes . 2024 Oct; 74(1):75-81. PMID: 39418322
Article Highlights:
4.
Messina R, Lenzi J, Rosa S, Fantini M, Bartolo P
Healthcare (Basel) . 2024 Oct; 12(19). PMID: 39408121
Background: Depression in type 2 diabetes mellitus (T2DM) impacts glycemic control and complications. This study examines the influence of depression on compliance with recommended annual diabetes assessments in patients within...
5.
Russo G, Manicardi V, Rocca A, Nicolucci A, Giandalia A, Lucisano G, et al.
Metab Syndr Relat Disord . 2024 Aug; 22(9):661-668. PMID: 39088376
Familial chylomicronemia syndrome (FCS) is a rare inherited condition due to lipoprotein lipase deficiency, characterized by hyperchylomicronemia and severe hypertriglyceridemia. Diagnosis is often delayed, thus increasing the risk of acute...
6.
Baccetti F, Crisafulli C, Andreozzi F, Mannino G, Nicolucci A, Michelli A, et al.
Diabetes Res Clin Pract . 2024 Jul; 214:111781. PMID: 39002933
Aims: Describing the evolution over time in the use of sulfonylureas (SUs) and the characteristics of patients at first prescription and at interruption of treatment with SUs. Methods: Retrospective evaluation...
7.
Messina R, Mezuk B, Rosa S, Iommi M, Fantini M, Lenzi J, et al.
Diabetes Res Clin Pract . 2024 Jun; 213:111760. PMID: 38925296
Aims: To examine whether age at type 2 diabetes onset is an independent predictor of dementia risk. Methods: Retrospective cohort drawn from healthcare administrative records of all inhabitants within Romagna's...
8.
Dei Cas A, Aldigeri R, Bellei G, Raffaeli D, Bartolo P, Sforza A, et al.
Acta Diabetol . 2024 Jun; 61(9):1177-1184. PMID: 38833007
Aims: To assess the effectiveness of the intermittent-scanned continuous glucose monitoring (isCGM) system in preventing severe hypoglycemic episodes and in improving glucose parameters and quality of life. Methods: Four hundred...
9.
Graziani V, Suprani T, Bartolo P, Marchetti F
Acta Diabetol . 2024 May; 61(8):1069-1076. PMID: 38700547
Aims: The present study assessed the transitioning process of young adults with type 1 diabetes mellitus (T1D) in Italy. Materials And Methods: We asked Pediatric Diabetes Centers (PDC) and Adult...
10.
Lenzi J, Messina R, Rosa S, Iommi M, Rucci P, Fantini M, et al.
Diabetes Res Clin Pract . 2024 Feb; 209:111561. PMID: 38325659
Aims: To investigate the risk of major depression and dementia in patients with type 2 diabetes, including dementia resulting from depression, and their impact on diabetes-related complications and mortality. Methods:...